Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment

Sci Rep. 2024 May 13;14(1):10883. doi: 10.1038/s41598-024-60495-8.

Abstract

The molecular categorization of colon cancer patients remains elusive. Gene set enrichment analysis (GSEA), which investigates the dysregulated genes among tumor and normal samples, has revealed the pivotal role of epithelial-to-mesenchymal transition (EMT) in colon cancer pathogenesis. In this study, we employed multi-clustering method for grouping data, resulting in the identification of two clusters characterized by varying prognostic outcomes. These two subgroups not only displayed disparities in overall survival (OS) but also manifested variations in clinical variables, genetic mutation, and gene expression profiles. Using the nearest template prediction (NTP) method, we were able to replicate the molecular classification effectively within the original dataset and validated it across multiple independent datasets, underscoring its robust repeatability. Furthermore, we constructed two prognostic signatures tailored to each of these subgroups. Our molecular classification, centered on EMT, hold promise in offering fresh insights into the therapy strategies and prognosis assessment for colon cancer.

Keywords: Cell cycle; Colon cancer; Molecular subtypes; Non-negative matrix factorization; Unsupervised cluster.

MeSH terms

  • Aged
  • Biomarkers, Tumor / genetics
  • Cluster Analysis
  • Colonic Neoplasms* / genetics
  • Colonic Neoplasms* / mortality
  • Colonic Neoplasms* / pathology
  • Colonic Neoplasms* / therapy
  • Epithelial-Mesenchymal Transition* / genetics
  • Female
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Prognosis
  • Transcriptome

Substances

  • Biomarkers, Tumor